rs199476083
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP5BS1_Supporting
The NM_005592.4(MUSK):c.2368G>A(p.Val790Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005592.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 9Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- fetal akinesia deformation sequence 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUSK | ENST00000374448.9 | c.2368G>A | p.Val790Met | missense_variant | Exon 15 of 15 | 5 | NM_005592.4 | ENSP00000363571.4 | ||
MUSK | ENST00000416899.7 | c.2344G>A | p.Val782Met | missense_variant | Exon 14 of 14 | 5 | ENSP00000393608.3 | |||
MUSK | ENST00000189978.10 | c.2110G>A | p.Val704Met | missense_variant | Exon 14 of 14 | 5 | ENSP00000189978.6 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000229 AC: 57AN: 249208 AF XY: 0.000207 show subpopulations
GnomAD4 exome AF: 0.000122 AC: 178AN: 1461712Hom.: 0 Cov.: 32 AF XY: 0.000127 AC XY: 92AN XY: 727138 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000164 AC: 25AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74326 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27588369, 24122059, 31892318, 20371544, 16794080, 25562515, 30429133, 34426522, 15496425, 25537362) -
- -
- -
Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Pathogenic:2
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 790 of the MUSK protein (p.Val790Met). This variant is present in population databases (rs199476083, gnomAD 0.04%). This missense change has been observed in individuals with congenital myasthenic syndrome (CMS) (PMID: 15496425, 24122059, 30429133). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8239). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MUSK protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MUSK function (PMID: 15496425, 23326516). For these reasons, this variant has been classified as Pathogenic. -
- -
Congenital myasthenic syndrome 9 Pathogenic:2
- -
- -
MUSK-related disorder Pathogenic:1
Variant summary: MUSK c.2368G>A (p.Val790Met) results in a conservative amino acid change located in the Protein kinase domain (IPR000719) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 249208 control chromosomes. c.2368G>A has been reported in the literature in multiple compound heterozygous individuals affected with congenital myasthenis syndrome (e.g. Chevessier_2004, Maggi_2015, Younas_2018). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effects were reduced protein levels and stability in vitro, altered agrin-dependent acetylcholine receptor aggregation in vitro, and disassociation of nerve terminals with acetylcholine aggregates in vivo (e.g. Chevessier_2004, BenAmmar_2013). The following publications have been ascertained in the context of this evaluation (PMID: 23326516, 15496425, 24122059, 30429133). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying the variant as pathogenic (n=2), likely pathogenic (n=1), or uncertain significance (n=2). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Fetal akinesia deformation sequence 1 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at